ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.

Morré DJ, Hostetler B, Taggart DJ, Morré DM, Musk AW, Robinson BW, Creaney J

Open source

DOI
10.1186/s12014-016-9103-3
Published
2016
Container
Clinical proteomics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12014-016-9103-3,
  title = {ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.},
  author = {Morré DJ and Hostetler B and Taggart DJ and Morré DM and Musk AW and Robinson BW and Creaney J},
  year = {2016},
  journal = {Clinical proteomics},
  doi = {10.1186/s12014-016-9103-3},
  url = {https://doi.org/10.1186/s12014-016-9103-3}
}

RIS

TY  - JOUR
TI  - ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.
AU  - Morré DJ
AU  - Hostetler B
AU  - Taggart DJ
AU  - Morré DM
AU  - Musk AW
AU  - Robinson BW
AU  - Creaney J
PY  - 2016
JO  - Clinical proteomics
DO  - 10.1186/s12014-016-9103-3
UR  - https://doi.org/10.1186/s12014-016-9103-3
ER  - 

APA

DJ, M., B, H., DJ, T., DM, M., AW, M., BW, R., & J, C. (2016). ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.. Clinical proteomics. https://doi.org/10.1186/s12014-016-9103-3

Source records